BD Medical, a segment of Becton, Dickinson and Company (BDX) announced the commercial launch of a new passive needle guard technology, BD UltraSafe PLUS. The BD UltraSafe PLUS Passive Needle Guard has received 510(k) clearance as an anti-needlestick safety device.
BD Medical said the product, in addition to offering needlestick safety in an easy-to-use one-handed device, is enhanced with ergonomic features designed to facilitate comfort and support for healthcare providers and patients. The device is designed to meet increasingly complex biotechnology drug requirements, including higher viscosity.
For comments and feedback: editorial@rttnews.com